DLT Resolution Inc. (DLTI)

Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0	0.01	0.03	0.01	0.01
Cash & Short-Term Investments	0	0.01	0.03	0.01	0.01
Cash Growth	-94.53%	-60.09%	288.51%	-41.66%	1.80%
Accounts Receivable	0.01	0.01	0.05	0.05	0.03
Other Receivables	0.21	-	-	-	-
Receivables	0.21	0.01	0.05	0.05	0.03
Total Current Assets	0.21	0.02	0.08	0.05	0.05
Goodwill	-	-	-	-	0.17
Other Intangible Assets	-	-	0.21	0.28	0.38
Other Long-Term Assets	-	0	1.07	3.19	-
Total Assets	0.21	0.02	1.36	3.52	0.59
Accounts Payable	0.06	0.06	0.22	0.19	0.11
Accrued Expenses	0.11	0.1	0.05	0.04	0.03
Short-Term Debt	0.09	0.16	0.08	0.08	0.1
Current Portion of Long-Term Debt	-	-	0.03	0.06	-
Other Current Liabilities	-	0.76	0.84	0.57	0.02
Total Current Liabilities	0.26	1.09	1.22	0.94	0.27
Long-Term Debt	-	-	0.01	0.01	0.01
Other Long-Term Liabilities	-	-	-	1.89	0.69
Total Liabilities	0.26	1.09	1.23	2.83	0.96
Common Stock	0.03	0.02	0.03	0.03	0.02
Additional Paid-In Capital	7.07	6.94	6.76	4.91	4.22
Retained Earnings	-7.48	-8.69	-6.55	-5.14	-4.65
Treasury Stock	-	-	-0.01	-0.01	-0.01
Comprehensive Income & Other	0.34	0.59	-0.17	0.83	-0.02
Total Common Equity	-0.05	-1.13	0.07	0.62	-0.43
Shareholders' Equity	-0.05	-1.06	0.13	0.69	-0.37
Total Liabilities & Equity	0.21	0.02	1.36	3.52	0.59
Total Debt	0.09	0.16	0.12	0.15	0.1
Net Cash (Debt)	-0.09	-0.15	-0.09	-0.14	-0.09
Net Cash Per Share	-0.00	-0.01	-0.00	-0.01	-0.00
Filing Date Shares Outstanding	62.21	21.5	21.11	22.11	21.22
Total Common Shares Outstanding	26.81	23.5	23.11	22.11	21.17
Working Capital	-0.05	-1.07	-1.14	-0.89	-0.22
Book Value Per Share	-0.00	-0.05	0.00	0.03	-0.02
Tangible Book Value	-0.05	-1.13	-0.15	0.35	-0.97
Tangible Book Value Per Share	-0.00	-0.05	-0.01	0.02	-0.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.